Detail akcie THC Farmaceuticals online

Business Summary: THC Farmaceuticals, Inc. is a clinical-stage biotechnology company. The Company specializes in the discovery, development, and commercialization of novel cannabinoid-based products in dental, ophthalmology and other medical disciplines. It offers the combination of its proprietary developments with its clinicians and scientists to unlock the therapeutic properties of cannabis and its bioactive compounds. The Company owns clinical research center and cannabidiol (CBD) manufacturing facility in California. Its business plan includes conducting cannabinoids research and development in collaboration with cannabis research centers worldwide with the goal of developing novel and advanced therapeutic methods for the treatment of common medical conditions with cannabis-based therapies and to conduct pre-clinical investigations and randomized, placebo-controlled trials of CBD-based compounds and develop condition-specific medications. It offers a network of micro vending kiosk systems.
Financial Summary: BRIEF: For the fiscal year ended 30 September 2022, THC Farmaceuticals Inc revenues increased from $2K to $10K. Net income totaled $427K vs. loss of $8K. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Gain on extinguishmentof debt increase from $0K to $435K (income), Generaland administrative decrease of 23% to $15K (expense).